Recombinant Human IgG1 Fc, CF, R&D Systems
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Manufacturer: R&D Systems 110HG100
DescriptionThe Recombinant Human IgG1 Fc Protein is derived from NS0. The Recombinant Human IgG1 Fc Protein has been validated for the following applications: Bioactivity.
This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|Mouse myeloma cell line,NS0-derived human IgG1 protein, (N-terminus) IEGRMD Human IgG1 (Pro100-Lys330) Substitutions: Leu117Ala,Leu118Glu,Gly120Ala,Thr276Ala Accession &Num; P01857 (C-terminus)|
|It is recommended that sterile PBS containing at least 0.1% human serum albumin or bovine serum albumin be added to the vial to prepare a stock solution of no less than 100 μg/mL.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok